首页|期刊导航|世界科学技术-中医药现代化|艾灸联合中药保留灌肠治疗慢性盆腔炎有效性和安全性的Meta分析

艾灸联合中药保留灌肠治疗慢性盆腔炎有效性和安全性的Meta分析OA

Meta Analysis of the Effectiveness and Safety of Moxibustion Combined with Traditional Chinese Medicine Retention Enema in the Treatment of Chronic Pelvic Inflammatory Disease

中文摘要英文摘要

目的 系统评价艾灸联合中药保留灌肠治疗慢性盆腔炎的有效性和安全性.方法 计算机检索PubMed、Embase、Cochrane Library、中国知网(CNKI)、中国生物医学文献服务系统(SinoMed)、万方数据库(Wanfang)、中文科技期刊数据库(VIP),全面收集各数据库自建立之日起至2024年8月16日期间,涉及艾灸联合中药保留灌肠治疗慢性盆腔炎的随机对照试验(Randomized controlled trial,RCT)(试验组与对照组是否配合常规治疗均纳入研究范畴).经双人独立完成文献筛选、数据提取后,运用Cochrane偏倚风险评估工具对纳入的文献进行方法学质量评价,最终采用RevMan 5.4统计分析软件实施Meta分析.结果 共纳入13 个RCT,共1235例患者,其中试验组619例,对照组616例.需要指出的是,本Meta分析所纳入的RCT结局指标选择较单一,部分指标仅来源于单项研究,结局指标证据薄弱.Meta分析结果显示,艾灸联合中药保留灌肠治疗慢性盆腔炎,在提高总有效率[RR=1.27,95%CI(1.20-1.34),P<0.01]、降低中医证候积分[MD=-1.50,95%CI(-2.02--0.98),P<0.01]、改善血清肿瘤坏死因子-α(Tumor necrosis factor-α,TNF-α)水平[SMD=-2.18,95%CI(-2.63--1.72),P<0.01]、改善血清白细胞介素(Interleukin,IL)-2水平[SMD=3.99,95%CI(3.36-4.61),P<0.01]、改善IL-10水平[SMD=0.94,95%CI(0.57-1.32),P<0.01]、降低血浆黏度水平[SMD=-3.63,95%CI(-4.47--2.79),P=0.0005]、降低血沉水平[SMD=-0.89,95%CI(-1.42--0.36),P=0.001]、生活质量评分[SMD=5.37,95%CI(4.59~6.14),P<0.01]、降低复发率[RR=0.20,95%CI(0.05-0.86),P=0.03]方面均优于单用中药保留灌肠.结论 艾灸联合中药灌肠治疗慢性盆腔炎具有重要的临床意义,当前应用广泛,医患评价较高,基于本Meta分析纳入的RCT临床证据显示,艾灸联合中药保留灌肠治疗慢性盆腔炎优于单用中药保留灌肠.然而特别指出的是,本Meta分析中部分结局指标的证据基础较为薄弱,七项结果仅来源于单项研究,建议后续研究优先采用量化评估工具(如标准化疼痛量表)及疾病进展相关客观指标(如症状恶化发生率),以增强研究结果的临床参考价值.

Objective Systematically evaluate the effectiveness and safety of moxibustion combined with traditional Chinese medicine retention enema in the treatment of chronic pelvic inflammatory disease.Methods Computer search PubMed,Embase,Cochrane Library,China National Knowledge Infrastructure(CNKI),The China Biomedical Literature Service System(SinoMed),Wanfang Database and Chinese Science and Technology Journal Database(VIP)comprehensively collected randomized controlled trials(RCTs)involving moxibustion combined with traditional Chinese medicine retention enema for the treatment of chronic pelvic inflammatory disease from the establishment of each database until August 16,2024(whether the experimental group and control group cooperated with conventional treatment were included in the research scope).After independent literature screening and data extraction by two individuals,the Cochrane bias risk assessment tool was used to evaluate the methodological quality of the included literature.Finally,RevMan 5.4 statistical analysis software was used to conduct meta-analysis.Results A total of 13 RCTs were included,with a total of 1235 patients,including 619 in the experimental group and 616 in the control group.It should be pointed out that the selection of outcome measures for the RCTs included in this meta-analysis is relatively single,and some indicators only come from single studies,resulting in weak evidence for outcome measures.The meta-analysis results showed that the combination of moxibustion and traditional Chinese medicine retention enema treatment for chronic pelvic inflammatory disease improved the overall effective rate[RR=1.27,95%CI(1.20-1.34),P<0.01],reduced the TCM syndrome score[MD=-1.50,95%CI(-2.02--0.98),P<0.01],improved serum TNF-α levels[SMD=-2.18,95%CI(-2.63--1.72),P<0.01],improved serum IL-2 levels[SMD=3.99,95%CI(3.36-4.61),P<0.01],improved IL-10 levels[SMD=0.94,95%CI(0.57-1.32),P<0.01],and reduced plasma viscosity levels[SMD=-3.63,95%CI(-4.47--2.79,P=0.0005],reduction of erythrocyte sedimentation rate(ESR)[SMD=-0.89,95%CI(-1.42--0.36),P=0.001],quality of life score[SMD=5.37,95%CI(4.59-6.14),P<0.01],and reduction of recurrence rate[RR=0.20,95%CI(0.05-0.86),P=0.03],it is superior to using traditional Chinese medicine retention enema alone.Conclusion The combination of moxibustion and traditional Chinese medicine enema for the treatment of chronic pelvic inflammatory disease has important clinical significance and is widely used with high evaluation from doctors and patients.Based on the RCT clinical evidence included in this meta-analysis,moxibustion combined with traditional Chinese medicine retention enema is superior to using traditional Chinese medicine retention enema alone for the treatment of chronic pelvic inflammatory disease.However,it should be noted that the evidence base for some outcome measures in this meta-analysis is relatively weak,and the seven results only come from a single study.It is recommended that future studies prioritize the use of quantitative evaluation tools(such as standardized pain scales)and objective indicators related to disease progression(such as the incidence of symptom deterioration)to enhance the clinical reference value of the research results.

于淼;刘倩;王宏;王彦博;李博

甘肃中医药大学护理学院 兰州 730000首都医科大学附属北京中医医院大数据与循证中心 北京 100010||北京市中医药研究所 北京中医药循证医学中心 北京 100010首都医科大学附属北京中医医院大数据与循证中心 北京 100010||北京市中医药研究所 北京中医药循证医学中心 北京 100010武警北京总队医院 北京 100027首都医科大学附属北京中医医院大数据与循证中心 北京 100010||北京市中医药研究所 北京中医药循证医学中心 北京 100010

医药卫生

慢性盆腔炎艾灸中药保留灌肠Meta分析系统评价随机对照试验

Chronic pelvic inflammatory diseaseMoxibustionTraditional Chinese medicine retention enemaMeta-analysisSystematic reviewRandomized controlled trial

《世界科学技术-中医药现代化》 2026 (1)

250-260,11

国家自然科学基金委员会面上项目(81774146):医患共建平行病历体现中医临床真实疗效的整体评价方法构建,负责人:李博北京市科学技术委员会科技新星计划2025年度交叉合作课题(20250484815):大模型赋能中西医患共建诊疗应用研究,负责人:李博.

10.11842/wst.20240928002

评论